Comment on "Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient" and "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab".
Pablo López SanzMarta Guzmán PérezClaudia Guerrero RamírezSilvia Manso CórdobaMaría Encarnación Alfaro MartínezJosé Manuel Azaña DefezPublished in: Clinical and experimental dermatology (2023)